REVA MEDICAL, INC - Announcements

Currently unlisted. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RVA	Presentation of Initial Fantom Results at TCT		16/10/15	1.71MB	Share
RVA	Fantom Presentation at Next-Generation Session		15/10/15	1.85MB	Share
RVA	Becoming a substantial holder		06/10/15	232.46KB	Share
RVA	Appendix 3B		06/10/15	349.28KB	Share
RVA	REVA Completes Clinical Enrollment Milestone	PRICE SENSITIVE	01/10/15	184.4KB	Share
RVA	Regina Groves Appointed as Chief Executive Officer	PRICE SENSITIVE	21/08/15	335.02KB	Share
RVA	Half Yearly Report and Accounts (Appendix 4D)	PRICE SENSITIVE	11/08/15	920.68KB	Share
RVA	Notice of Briefing Call		06/08/15	169.9KB	Share
RVA	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	351KB	Share
RVA	Appendix 3B		10/07/15	390.13KB	Share
RVA	Updated Insider Trading Policy		16/06/15	326.67KB	Share
RVA	Change of Director's Interest Notice		10/06/15	209.26KB	Share
RVA	Change of Director's Interest Notice		09/06/15	221.89KB	Share
RVA	Appendix 3B		04/06/15	402.12KB	Share
RVA	Change of Director's Interest Notice		03/06/15	215.36KB	Share
RVA	Change of Director's Interest Notice		03/06/15	221.92KB	Share
RVA	Change of Director's Interest Notice		03/06/15	211.06KB	Share
RVA	Change of Director's Interest Notice		03/06/15	211.81KB	Share
RVA	Change of Director's Interest Notice		03/06/15	208.41KB	Share
RVA	Change of Director's Interest Notice		03/06/15	215.6KB	Share
RVA	Change of Director's Interest Notice		03/06/15	209.59KB	Share
RVA	AGM Results		28/05/15	272.46KB	Share
RVA	AGM Presentation		28/05/15	2.83MB	Share
RVA	Initial Clinical Results for Fantom Scaffold	PRICE SENSITIVE	22/05/15	3.06MB	Share
RVA	REVA to Present at EuroPCR Conference		18/05/15	173.96KB	Share
RVA	FANTOM II Clinical Trial Expanded to Australia	PRICE SENSITIVE	15/05/15	193.61KB	Share
RVA	Quarterly Report on Form 10-Q & AGM Dial-In Details		15/05/15	980.57KB	Share
RVA	REVA Undertakes Search for Chief Executive Officer	PRICE SENSITIVE	14/05/15	193.94KB	Share
RVA	Proxy Statement for 2015 AGM		01/05/15	994.95KB	Share
RVA	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	355.99KB	Share
RVA	Fantom II Clinical Trial Expanded to Europe	PRICE SENSITIVE	23/04/15	53.29KB	Share
RVA	Initial Director's Interest Notice		01/04/15	58.18KB	Share
RVA	Annual Report on Form 10-K		31/03/15	883.18KB	Share
RVA	Form S-8 Filed with SEC		31/03/15	119.91KB	Share
RVA	Scott Huennekens Appointed to Board of Directors		26/03/15	54.65KB	Share
RVA	Notice of Briefing Call		24/03/15	48.63KB	Share
RVA	Appendix 3B		24/03/15	226.11KB	Share
RVA	Initiation of FANTOM II Clinical Trial & Live Implant at ACC	PRICE SENSITIVE	16/03/15	54.51KB	Share
RVA	Preliminary Final Report	PRICE SENSITIVE	27/02/15	411.11KB	Share
RVA	Presentations at CRT Conference		24/02/15	3.2MB	Share
RVA	Initial Director's Interest Notice		05/02/15	58.18KB	Share
RVA	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	139.2KB	Share
RVA	Dr. Ross Breckenridge Appointed to Board of Directors		29/01/15	51.97KB	Share
RVA	Presentation at J.P. Morgan Healthcare Conference		16/01/15	2.06MB	Share
RVA	REVA to Present at J.P. Morgan Healthcare Conference		12/01/15	48.45KB	Share
RVA	Change of Auditors		22/12/14	48.41KB	Share
RVA	Change in Registered Office		05/12/14	48.3KB	Share
RVA	REVA Implants First Patients with Fantom Scaffold	PRICE SENSITIVE	04/12/14	52.6KB	Share
RVA	Change of Director's Interest Notice		26/11/14	76.06KB	Share
RVA	REVA Closes Financing		21/11/14	52.07KB	Share
RVA	Appendix 3B		14/11/14	181.35KB	Share
RVA	Quarterly Report on Form 10-Q		07/11/14	262.59KB	Share
RVA	Notice of Briefing Call		05/11/14	53.26KB	Share
RVA	Results of Special Meeting		31/10/14	110.77KB	Share
RVA	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	125.86KB	Share
RVA	Prospectus for Offering of Convertible Notes and Options	PRICE SENSITIVE	24/10/14	319.98KB	Share
RVA	Details for Special Meeting of Stockholders		23/10/14	46.87KB	Share
RVA	Appendix 3B		22/10/14	187.95KB	Share
RVA	Update to Proxy Statement for 2014 Special Meeting		16/10/14	919.47KB	Share
RVA	Proxy Statement for 2014 Special Meeting of Stockholders		15/10/14	919.02KB	Share
RVA	Appendix 3B		30/09/14	236.76KB	Share
RVA	Notice of Company Update Call		26/09/14	46.99KB	Share
RVA	Goldman Sachs and Senrigan to Provide Financing	PRICE SENSITIVE	26/09/14	87.93KB	Share
RVA	Presentation at TCT 2014 Conference		17/09/14	50.63KB	Share
RVA	Change to Company's Bylaws		15/09/14	47.97KB	Share
RVA	Half Yearly Report and Accounts (Appendix 4D)	PRICE SENSITIVE	08/08/14	279.08KB	Share
RVA	Notice of Briefing Call		06/08/14	45.84KB	Share
RVA	Chairman's Letter to Stockholders		01/08/14	291.86KB	Share
RVA	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/14	139.99KB	Share
RVA	Final Director's Interest Notice		30/07/14	61.69KB	Share
RVA	Presentation at Bioresorbable Vascular Scaffold Conference		25/07/14	1.7MB	Share
RVA	Board Member James Schiro Resigns for Health Reasons		25/07/14	44.79KB	Share
RVA	Presentation at Wells Fargo Healthcare Conference		17/06/14	44.82KB	Share
RVA	Symposium Presentations at PCR		22/05/14	4.54MB	Share
RVA	Appendix 3B		15/05/14	168.66KB	Share
RVA	Change of Director's Interest Notice		15/05/14	70.39KB	Share
RVA	Change of Director's Interest Notice		15/05/14	73.15KB	Share
RVA	Change of Director's Interest Notice		14/05/14	71.29KB	Share
RVA	Change of Director's Interest Notice		14/05/14	70.77KB	Share
RVA	Change of Director's Interest Notice		14/05/14	70.3KB	Share
RVA	AGM Results		13/05/14	119.19KB	Share
RVA	AGM Presentation		13/05/14	2.25MB	Share
RVA	Quarterly Report on Form 10-Q		09/05/14	246.83KB	Share
RVA	AGM Dial-In Details		06/05/14	48.21KB	Share
RVA	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/14	205.39KB	Share
RVA	Proxy Statement for 2014 AGM & Operations Update Call		03/04/14	1.07MB	Share
RVA	Notice of Company Update Call		01/04/14	52.96KB	Share
RVA	REVA to Focus on FANTOM Scaffold	PRICE SENSITIVE	27/03/14	54.73KB	Share
RVA	Presentations at SIR & Polymers and Plastics Conferences		25/03/14	512.91KB	Share
RVA	Annual Report on Form 10-K		18/03/14	874.4KB	Share
RVA	Form S-8 Filed with SEC		18/03/14	117.83KB	Share
RVA	Preliminary Final Report	PRICE SENSITIVE	27/02/14	328.52KB	Share
RVA	Notice of Briefing Call and Cowen HC Conference Presentation		24/02/14	51.06KB	Share
RVA	Presentation at CRT Conference		24/02/14	47.52KB	Share
RVA	REVA Hires VP General Counsel		11/02/14	58KB	Share
RVA	Appendix 3B		31/01/14	220.35KB	Share
RVA	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14	208.85KB	Share
RVA	Appendix 3B		16/01/14	220.61KB	Share
RVA	Clinical Enrollment Completion & JP Morgan Presentation		14/01/14	55.37KB	Share
RVA	Change of Director's Interest Notice		20/12/13	70.89KB	Share

RVA Presentation of Initial Fantom Results at TCT
16/10/15		1.71MB	Share
RVA Fantom Presentation at Next-Generation Session
15/10/15		1.85MB	Share
RVA Becoming a substantial holder
06/10/15		232.46KB	Share
RVA Appendix 3B
06/10/15		349.28KB	Share
RVA REVA Completes Clinical Enrollment Milestone
01/10/15	PRICE SENSITIVE	184.4KB	Share
RVA Regina Groves Appointed as Chief Executive Officer
21/08/15	PRICE SENSITIVE	335.02KB	Share
RVA Half Yearly Report and Accounts (Appendix 4D)
11/08/15	PRICE SENSITIVE	920.68KB	Share
RVA Notice of Briefing Call
06/08/15		169.9KB	Share
RVA Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	351KB	Share
RVA Appendix 3B
10/07/15		390.13KB	Share
RVA Updated Insider Trading Policy
16/06/15		326.67KB	Share
RVA Change of Director's Interest Notice
10/06/15		209.26KB	Share
RVA Change of Director's Interest Notice
09/06/15		221.89KB	Share
RVA Appendix 3B
04/06/15		402.12KB	Share
RVA Change of Director's Interest Notice
03/06/15		215.36KB	Share
RVA Change of Director's Interest Notice
03/06/15		221.92KB	Share
RVA Change of Director's Interest Notice
03/06/15		211.06KB	Share
RVA Change of Director's Interest Notice
03/06/15		211.81KB	Share
RVA Change of Director's Interest Notice
03/06/15		208.41KB	Share
RVA Change of Director's Interest Notice
03/06/15		215.6KB	Share
RVA Change of Director's Interest Notice
03/06/15		209.59KB	Share
RVA AGM Results
28/05/15		272.46KB	Share
RVA AGM Presentation
28/05/15		2.83MB	Share
RVA Initial Clinical Results for Fantom Scaffold
22/05/15	PRICE SENSITIVE	3.06MB	Share
RVA REVA to Present at EuroPCR Conference
18/05/15		173.96KB	Share
RVA FANTOM II Clinical Trial Expanded to Australia
15/05/15	PRICE SENSITIVE	193.61KB	Share
RVA Quarterly Report on Form 10-Q & AGM Dial-In Details
15/05/15		980.57KB	Share
RVA REVA Undertakes Search for Chief Executive Officer
14/05/15	PRICE SENSITIVE	193.94KB	Share
RVA Proxy Statement for 2015 AGM
01/05/15		994.95KB	Share
RVA Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	355.99KB	Share
RVA Fantom II Clinical Trial Expanded to Europe
23/04/15	PRICE SENSITIVE	53.29KB	Share
RVA Initial Director's Interest Notice
01/04/15		58.18KB	Share
RVA Annual Report on Form 10-K
31/03/15		883.18KB	Share
RVA Form S-8 Filed with SEC
31/03/15		119.91KB	Share
RVA Scott Huennekens Appointed to Board of Directors
26/03/15		54.65KB	Share
RVA Notice of Briefing Call
24/03/15		48.63KB	Share
RVA Appendix 3B
24/03/15		226.11KB	Share
RVA Initiation of FANTOM II Clinical Trial & Live Implant at ACC
16/03/15	PRICE SENSITIVE	54.51KB	Share
RVA Preliminary Final Report
27/02/15	PRICE SENSITIVE	411.11KB	Share
RVA Presentations at CRT Conference
24/02/15		3.2MB	Share
RVA Initial Director's Interest Notice
05/02/15		58.18KB	Share
RVA Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	139.2KB	Share
RVA Dr. Ross Breckenridge Appointed to Board of Directors
29/01/15		51.97KB	Share
RVA Presentation at J.P. Morgan Healthcare Conference
16/01/15		2.06MB	Share
RVA REVA to Present at J.P. Morgan Healthcare Conference
12/01/15		48.45KB	Share
RVA Change of Auditors
22/12/14		48.41KB	Share
RVA Change in Registered Office
05/12/14		48.3KB	Share
RVA REVA Implants First Patients with Fantom Scaffold
04/12/14	PRICE SENSITIVE	52.6KB	Share
RVA Change of Director's Interest Notice
26/11/14		76.06KB	Share
RVA REVA Closes Financing
21/11/14		52.07KB	Share
RVA Appendix 3B
14/11/14		181.35KB	Share
RVA Quarterly Report on Form 10-Q
07/11/14		262.59KB	Share
RVA Notice of Briefing Call
05/11/14		53.26KB	Share
RVA Results of Special Meeting
31/10/14		110.77KB	Share
RVA Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	125.86KB	Share
RVA Prospectus for Offering of Convertible Notes and Options
24/10/14	PRICE SENSITIVE	319.98KB	Share
RVA Details for Special Meeting of Stockholders
23/10/14		46.87KB	Share
RVA Appendix 3B
22/10/14		187.95KB	Share
RVA Update to Proxy Statement for 2014 Special Meeting
16/10/14		919.47KB	Share
RVA Proxy Statement for 2014 Special Meeting of Stockholders
15/10/14		919.02KB	Share
RVA Appendix 3B
30/09/14		236.76KB	Share
RVA Notice of Company Update Call
26/09/14		46.99KB	Share
RVA Goldman Sachs and Senrigan to Provide Financing
26/09/14	PRICE SENSITIVE	87.93KB	Share
RVA Presentation at TCT 2014 Conference
17/09/14		50.63KB	Share
RVA Change to Company's Bylaws
15/09/14		47.97KB	Share
RVA Half Yearly Report and Accounts (Appendix 4D)
08/08/14	PRICE SENSITIVE	279.08KB	Share
RVA Notice of Briefing Call
06/08/14		45.84KB	Share
RVA Chairman's Letter to Stockholders
01/08/14		291.86KB	Share
RVA Appendix 4C - quarterly
31/07/14	PRICE SENSITIVE	139.99KB	Share
RVA Final Director's Interest Notice
30/07/14		61.69KB	Share
RVA Presentation at Bioresorbable Vascular Scaffold Conference
25/07/14		1.7MB	Share
RVA Board Member James Schiro Resigns for Health Reasons
25/07/14		44.79KB	Share
RVA Presentation at Wells Fargo Healthcare Conference
17/06/14		44.82KB	Share
RVASymposium Presentations at PCR
22/05/14		4.54MB	Share
RVAAppendix 3B
15/05/14		168.66KB	Share
RVAChange of Director's Interest Notice
15/05/14		70.39KB	Share
RVAChange of Director's Interest Notice
15/05/14		73.15KB	Share
RVAChange of Director's Interest Notice
14/05/14		71.29KB	Share
RVAChange of Director's Interest Notice
14/05/14		70.77KB	Share
RVAChange of Director's Interest Notice
14/05/14		70.3KB	Share
RVAAGM Results
13/05/14		119.19KB	Share
RVAAGM Presentation
13/05/14		2.25MB	Share
RVAQuarterly Report on Form 10-Q
09/05/14		246.83KB	Share
RVAAGM Dial-In Details
06/05/14		48.21KB	Share
RVAAppendix 4C - quarterly
30/04/14	PRICE SENSITIVE	205.39KB	Share
RVAProxy Statement for 2014 AGM & Operations Update Call
03/04/14		1.07MB	Share
RVANotice of Company Update Call
01/04/14		52.96KB	Share
RVAREVA to Focus on FANTOM Scaffold
27/03/14	PRICE SENSITIVE	54.73KB	Share
RVAPresentations at SIR & Polymers and Plastics Conferences
25/03/14		512.91KB	Share
RVAAnnual Report on Form 10-K
18/03/14		874.4KB	Share
RVAForm S-8 Filed with SEC
18/03/14		117.83KB	Share
RVAPreliminary Final Report
27/02/14	PRICE SENSITIVE	328.52KB	Share
RVANotice of Briefing Call and Cowen HC Conference Presentation
24/02/14		51.06KB	Share
RVAPresentation at CRT Conference
24/02/14		47.52KB	Share
RVAREVA Hires VP General Counsel
11/02/14		58KB	Share
RVAAppendix 3B
31/01/14		220.35KB	Share
RVAAppendix 4C - quarterly
31/01/14	PRICE SENSITIVE	208.85KB	Share
RVAAppendix 3B
16/01/14		220.61KB	Share
RVAClinical Enrollment Completion & JP Morgan Presentation
14/01/14		55.37KB	Share
RVAChange of Director's Interest Notice
20/12/13		70.89KB	Share

REFRESH

First 2 3 4

REVA MEDICAL, INC - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available